Indications and uses
Uses Temporarily relieves the symptoms of the common cold, including: runny nose sore throat sneezing cough post nasal drip nasal or chest congestion
Uses Temporarily relieves the symptoms of the common cold, including: runny nose sore throat sneezing cough post nasal drip nasal or chest congestion
Shake well before using. Measure only with the dosing cup provided. Do not use dosing cup with other products. On dosing cup, mL = milliliter. Children 6 years to under 12 years Adults and children 12 years and over Children 2 years to under 6 years 10 mL up to 6 times per day (every 4 hours) 15 mL up to 6 times per day (every 4 hours)
Uses
Temporarily relieves the symptoms of the common cold, including:
runny nose
sore throat
sneezing
cough
post nasal drip
nasal or chest congestion
Shake well before using.
Measure only with the dosing cup provided.
Do not use dosing cup with other products.
On dosing cup, mL = milliliter.
Children 6 years
to under 12 years
Adults and children
12 years and over
Children 2 years
to under 6 years
10 mL up to 6 times per day
(every 4 hours)
15 mL up to 6 times per day
(every 4 hours)
■ Helps temporarily relieve symptoms of common cold in children, including:
■ runny nose ■sore throat ■ sneezing ■ cough
■ post nasal drip ■ nasal or chest congestion
| Active ingredients | Purpose* |
| Allium Cepa 6X HPUS | watery/runny nose, cold, hacking cough, painful throat |
| Hepar Sulph Calc 12X HPUS | cold, sneezing |
| Hydrastis 6X HPUS | rattling/tickling cough, sinus congestion, dry/raw/sore throat |
| Natrum Muriaticum 6X HPUS | dry cough, sore throat |
| Phosphorus 12X HPUS | hoarse/dry cough, nasal congestion, chest congestion |
| Pulsatilla 6X HPUS | moist cough, cold, post nasal drip |
| Sulphur 12X HPUS | chest congestion, nasal congestion, sneezing, runny nose |
"HPUS" is the Homeopathic Pharmacopoeia of the United States.
■ Helps temporarily relieve symptoms of common cold in children, including:
■ runny nose ■ sore throat ■ sneezing ■ cough
■ post nasal drip ■ nasal or chest congestion
If sore throat is severe, persists for more than 2 days, is accompanied or followed by fever, headache, rash, nausea, or vomiting, consult a doctor promptly.
■ persistent or chronic cough such as smoking, asthma, chronic bronchitis or emphysema. A persistent cough may be a sign of a serious condition. ■ cough that is accompanied by excessive phlegm (mucus).
■ symptoms persist for more than 7 days or worsen. ■ inflammation, fever or infection is present or develops. ■ cough tends to recur or is accompanied by a fever, rash or persistent headache.
Ask a health professional before use.
■ Use as directed. ■ Do not refrigerate. ■ Shake well before using. ■ Measure only with the dosing cup provided. ■ Do not use
dosing cup with other products. ■ On dosing cup, mL = milliliter.
| Children 2 years
to under 6 years | 5 mL up to 6 times per day
(every 4 hours). |
| Children 6 years
to under 12 years | 10 mL up to 6 times per day
(every 4 hours). |
| Adults and children
12 years and over | 15 mL up to 6 times per day
(every 4 hours). |
Citric Acid, Glycerine, Glycyrrhiza Extract, Purified Water, Sodium Benzoate.
www.hylands.com or care@hylands.com
Helps temporarily relieve symptoms of common cold in children, including: runny nose, sore throat, sneezing, cough, post nasal drip, nasal or chest congestion.
Hyland's
NATURALS
•Kids•
Cold &
Cough*
DAYTIME
NO ALCOHOL, SUGAR,
PARABENS or DYES
Congestion*
Runny Nose*
Sore Throat*
Cough*
Post Nasal
Drip*
2 -12
YEARS
4 FL. OZ.
HOMEOPATHIC
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 54973-3075-1 | Cold and Cough 4 Kids | 118 mL in 1 BOTTLE, PLASTIC | LIQUID | 118 | 12 | |
| 54973-3075-2 | Cold and Cough 4 Kids | 1 in 1 CARTON | LIQUID | 1 | 12 | |
| 54973-3075-2 | Cold and Cough 4 Kids | 19.8 mL in 1 BOTTLE, PLASTIC | LIQUID | 19.8 | 12 | |
| 54973-3075-3 | Cold and Cough 4 Kids | 5 mL in 1 POUCH | LIQUID | 5 | 12 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| CALCIUM SULFIDE | ACTIVE INGREDIENT | 1MBW07J51Q | 3 | |
| GOLDENSEAL | ACTIVE INGREDIENT | ZW3Z11D0JV | 3 | |
| ONION | ACTIVE INGREDIENT | 492225Q21H | 3 | |
| PHOSPHORUS | ACTIVE INGREDIENT | 27YLU75U4W | 3 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 3 | |
| SODIUM CHLORIDE | ACTIVE INGREDIENT | 451W47IQ8X | 3 | |
| SULFUR | ACTIVE INGREDIENT | 70FD1KFU70 | 3 | |
| CALCIUM SULFIDE | ACTIVE MOIETY | 1MBW07J51Q | 3 | |
| GOLDENSEAL | ACTIVE MOIETY | ZW3Z11D0JV | 3 | |
| ONION | ACTIVE MOIETY | 492225Q21H | 3 | |
| PHOSPHORUS | ACTIVE MOIETY | 27YLU75U4W | 3 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 3 | |
| SODIUM CATION | ACTIVE MOIETY | LYR4M0NH37 | 3 | |
| SULFUR | ACTIVE MOIETY | 70FD1KFU70 | 3 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 3 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 3 | |
| GLYCYRRHIZA GLABRA | INACTIVE INGREDIENT | 2788Z9758H | 3 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 3 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 3 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 54973-3075 | 54973-3075-1, 54973-3075-2, 54973-3075-3 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| CITRIC ACID MONOHYDRATE | 2968PHW8QP | IACT |
| GLYCYRRHIZA GLABRA | 2788Z9758H | IACT |
| WATER | 059QF0KO0R | IACT |
| SODIUM BENZOATE | OJ245FE5EU | IACT |
| GLYCERIN | PDC6A3C0OX | IACT |
| ONION | 492225Q21H | ACTIB |
| CALCIUM SULFIDE | 1MBW07J51Q | ACTIB |
| SODIUM CHLORIDE | 451W47IQ8X | ACTIB |
| PHOSPHORUS | 27YLU75U4W | ACTIB |
| ANEMONE PULSATILLA | I76KB35JEV | ACTIB |
| SULFUR | 70FD1KFU70 | ACTIB |
| GOLDENSEAL | ZW3Z11D0JV | ACTIB |
| Version | Effective date | Source | Hydrated |
|---|---|---|---|
| 10 | 2023-07-31 | full-release | 2026-06-01 02:21:58 |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SOLUTION / ORAL | 660 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, EFFERVESCENT / ORAL | 60 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE / ORAL | 28 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | ELIXIR / ORAL | 5.02 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CAPSULE / ORAL | 8.5 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, EXTENDED RELEASE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SYRUP / ORAL | 80 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, FILM COATED / ORAL | 1 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION / ORAL | 320 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION/ DROPS / ORAL | 23 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SOLUTION / ORAL | 98 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | POWDER, FOR SUSPENSION / ORAL | 160 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, COATED / ORAL | 0.2 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET / ORAL | 30 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE, FOR SUSPENSION / ORAL | 120 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | CONCENTRATE / ORAL | 20 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cold and Cough 4 Kids | ONION, CALCIUM SULFIDE, SODIUM CHLORIDE, PHOSPHORUS, PULSATILLA VULGARIS, SULFUR, AND GOLDENSEAL | Hyland's Inc. | e06599ca-fc94-4b2c-829e-f3d4ec866ed6 | 2025-10-29 | Warnings | 54973-3075-3 54973-3075-2 54973-3075-1 54973-3075 54973307502 54973307501 54973307503 4250c93f-a9aa-9175-e063-6294a90a0332 e06599ca-fc94-4b2c-829e-f3d4ec866ed6 |
Adverse event summaries are temporarily unavailable. Other product information remains available.